引用次数
引用: 19,070
H-指数: 69
I10-指数 : 201
出版物: 631
Computerized Quantitative Imaging Assessment of Tumor Burden
Andrew Quon , Daniel L. Rubin , Sandy Napel , George Fisher
2014
Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies
Bo Shi , Hsin-Ling Hsu , Andy M. Evens , Leo I. Gordon
Blood 102 ( 1) 297 -302
33
2003
Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-World Analysis
Andrzej Stadnik , Stephen D. Smith , Deepa Jagadeesh , Lori A. Leslie
Blood 134 402 -402
6
2019
Treatment with Full Chemotherapy Regimens in Older Adults with Hodgkin Lymphoma Improves 3-Year Overall Survival, but Less Than Half Receive Full Regimens
Angie Mae Rodday , Theresa E. Hahn , Anita J Kumar , Peter K Lindenauer
Blood 134 1563 -1563
1
2019
A Multi-Institution Analysis of Relapsed Lymphoma Occurring during Pregnancy Including Pharmacokinetics with Antenatal Checkpoint Inhibitor Therapy
Faheem Farooq , Elyce Cardonick , Evgenia Polushkina , Sairah Ahmed
Blood 138 2457 -2457
2021
FLIPI-3: A New PET-Based Prognostic Index for Follicular Lymphoma Based on Results from a Validation Study with the ECOG-ACRIN E2408 Cohort
Frederique St-Pierre , Stephen Broski , Zequn Sun , Masha Kocherginsky
Blood 140 ( Supplement 1) 6480 -6481
2022
High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Central Nervous System (CNS) Involvement, Prophylaxis, and Recurrence Risk in a Multi-Institutional Series
Narendranath Epperla , Adam Zayac , Daniel J Landsburg , Mitchell Hughes
Blood 140 ( Supplement 1) 3839 -3841
2
2022
Weight Change Trends and Impact of Body Mass Index (BMI) on Outcomes in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma, a Retrospective Analysis from the Lymphoma Innovations Orien Network (LION) Consortium
Yazeed Sawalha , Chenxi Du , Jeffrey M Switchenko , Melissa Kives
Blood 140 ( Supplement 1) 11956 -11958
2022
Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
A EVENS , C BENNETT , S LUMINARI
Best Practice & Research Clinical Haematology 18 ( 3) 481 -489
23
2005
Clinical characteristics of erythropoietin- associated pure red cell aplasia
K CARSON , A EVENS , C BENNETT , S LUMINARI
Best Practice & Research Clinical Haematology 18 ( 3) 467 -472
16
2005
Hodgkin lymphoma: epidemiology, diagnosis, and treatment
MA Evens , JS Horning
Management of Hematologic Malignancies 367 -403
3
2010
HMG-CoA reductase inhibitors in secondary prevention of coronary heart disease: comparison of expense per year of life gained
TL Skaer , DA Sclar , MA Evens , SK Mukherjee
American Journal of Cariology 87 ( Suppl R) 21 -25
2001
Motexafin gadolinium (MGd) is cytotoxic to steroid and chemotherapy-resistant myeloma cell lines: Striking enhancment of apoptosis by redox regulation.
AGB Evens , S Prachand , J Nelson , R Miller
Blood 100 ( 11) 380B -380B
2
2002
Update on approaches to the treatment of follicular lymphoma
ANDREW M Evens , JANE N Winter
Clinical Oncology News Special Edition 20 -30
1
2011
Diffuse large B-cell lymphoma associated with the use of biologic and other investigational agents: the importance of long-term post-marketing safety surveillance.
Andrew M. Evens , Anne Laumann , Allison Goddard , Dennis P. West
Journal of Drugs in Dermatology 10 ( 1) 80 -83
4
2011
Inhibition of Bromodomain Proteins in Treatment of Diffuse Large B-cell Lymphoma
Andrew M. Evens , James E. Bradner , Rachel M. Gerstein , Dale L. Greiner
2014
Motexafin gadolinium enhances p53-Mdm2 interactions, reducing p53 and downstream targets in lymphoma cell lines.
Andrew M. Evens , Sheila N. Prachand , Amareshwar T.K. Singh , Leo I. Gordon
Anticancer Research 30 ( 4) 1131 -1136
4
2010
Improving outcomes in PTLD.
Andrew M. Evens
Oncology 24 ( 10)
2
2010
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
Andrew M Evens , Alexey Danilov , Deepa Jagadeesh , Amy Sperling
Blood 137 ( 3) 374 -386
3
2021
EBV-Positive Primary CNS Lymphomas in Older Patients: Incidence, Characteristics, Tumor Pathology, and Outcomes across a Large Multicenter Cohort
Veronika Bachanova , Andrew M. Evens , Narendranath Epperla , Samuel Goldlust
Blood 136 4 -6
2020
Leo I Gordon Jane N. Winter Afshin Beheshti Savita Bhalla Randy D Gascoyne Jeremy S. Abramson Fangxin Hong Eric Hsi Martin Hutchings Barbara Pro Richard I. Fisher Monika Pilichowska J. Tyson Mcdonald Saheli Sarkar Dennis West Paolo Caimi Aaron S Rosenberg Richard Hoppe Dixon Kaufman Mary Gospodarowicz